CD80 and cancer: In this context, our finding that Ad5FB4 acted as a ligand of B7.1 monomer, and that Ad5FB4 penton negatively interferred with B7.1/B7-H1 heterodimer formation, made Ad5FB4 a unique adenoviral vector for cancer gene therapy, as it targeted cell surface molecules involved in the immunoevasion mechanisms.